IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ten Berge, P. J.
Right arrow Articles by Ruiter, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ten Berge, P. J.
Right arrow Articles by Ruiter, D. J.

Investigative Ophthalmology & Visual Science, Vol 34, 3635-3640, Copyright © 1993 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Integrin expression in uveal melanoma differs from cutaneous melanoma

PJ ten Berge, EH Danen, GN van Muijen, MJ Jager and DJ Ruiter
Department of Pathology, University Hospital Nijmegen, The Netherlands.

PURPOSE. During the process of metastasis, changes in cell-cell and cell-matrix contacts occur; therefore, expression of integrins, a superfamily of adhesion molecules, may be important. Expression of integrins has been studied extensively in cutaneous melanoma. Because it is known that uveal melanoma has a metastatic behavior different from cutaneous melanoma, the authors investigated integrin expression in uveal melanoma. METHODS. The authors used monoclonal antibodies recognizing integrin subunits alpha 1-6, alpha v, beta 1, and beta 4 and integrins alpha v beta 3 and alpha v beta 5 on frozen sections of 32 human primary uveal melanomas and 4 metastases, followed by an avidin-biotin-peroxidase complex-immunoperoxidase technique. RESULTS. As in cutaneous melanoma, alpha 4 expression was rare, but most lesions expressed alpha 3 and alpha 6. In contrast to cutaneous melanoma, in which alpha 2 is well expressed in most lesions and alpha 5 is expressed only in a small percentage of lesions, alpha 2 expression was rare in uveal melanoma and alpha 5 expression was found in all lesions. A major difference was observed with regard to the alpha v beta 3 vitronectin receptor. In contrast to cutaneous melanoma, in which alpha v beta 3 is expressed in advanced primary melanomas and metastases, alpha v beta 3 was not detected in any of the primary uveal melanomas, but all lesions strongly expressed alpha v beta 5. CONCLUSIONS. Integrin expression in uveal melanoma cannot be correlated with cell type or invasiveness. In contrast to cutaneous melanoma, it seems that determination of the integrin expression profile is not suitable for categorizing uveal melanomas as less malignant and highly malignant lesions.


This article has been cited by other articles:


Home page
 Br. J. Ophthalmol.Home page
S. R Elshaw, K. Sisley, N. Cross, A. K Murray, S. M MacNeil, M. Wagner, C. E Nichols, and I. G Rennie
A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of {alpha}1{beta}1, {alpha}4{beta}1 and {alpha}6{beta}1 integrins
Br. J. Ophthalmol., June 1, 2001; 85(6): 732 - 738.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
G. Anastassiou, H. Schilling, S. Djakovic, and N. Bornfeld
Expression of VLA-2, VLA-3, and alpha v integrin receptors in uveal melanoma: association with microvascular architecture of the tumour and prognostic value
Br. J. Ophthalmol., August 1, 2000; 84(8): 899 - 902.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the Association for Research in Vision and Ophthalmology